Clinical Trial Update: Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating standard idarubicin and cytarabine for acute myeloid leukemia has completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• idarubicin and cytarabine (standard regimen)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-06-12